Walleye Capital LLC Invests $6.26 Million in Option Care Health, Inc. $OPCH

Key Points

Error: Response status code does not indicate success: 500 (Internal Server Error).

Walleye Capital LLC purchased a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 179,219 shares of the company's stock, valued at approximately $6,264,000. Walleye Capital LLC owned 0.11% of Option Care Health at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the business. Public Employees Retirement System of Ohio raised its position in Option Care Health by 21.6% during the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after buying an additional 332 shares during the period. US Bancorp DE increased its position in Option Care Health by 5.0% in the 1st quarter. US Bancorp DE now owns 8,199 shares of the company's stock worth $287,000 after purchasing an additional 393 shares during the last quarter. State of Michigan Retirement System increased its position in Option Care Health by 1.2% in the 1st quarter. State of Michigan Retirement System now owns 40,759 shares of the company's stock worth $1,425,000 after purchasing an additional 500 shares during the last quarter. Louisiana State Employees Retirement System increased its position in Option Care Health by 1.1% in the 1st quarter. Louisiana State Employees Retirement System now owns 47,700 shares of the company's stock worth $1,667,000 after purchasing an additional 500 shares during the last quarter. Finally, State of Alaska Department of Revenue increased its position in Option Care Health by 2.7% in the 1st quarter. State of Alaska Department of Revenue now owns 19,931 shares of the company's stock worth $696,000 after purchasing an additional 525 shares during the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 36,000 shares of Option Care Health stock in a transaction on Wednesday, August 20th. The stock was bought at an average price of $27.15 per share, for a total transaction of $977,400.00. Following the transaction, the director owned 375,390 shares of the company's stock, valued at $10,191,838.50. The trade was a 10.61% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Timothy P. Sullivan acquired 20,000 shares of Option Care Health stock in a transaction on Thursday, August 21st. The stock was purchased at an average price of $27.51 per share, with a total value of $550,200.00. Following the transaction, the director directly owned 49,229 shares in the company, valued at approximately $1,354,289.79. This trade represents a 68.43% increase in their position. The disclosure for this purchase can be found here. 0.64% of the stock is currently owned by company insiders.

Option Care Health Stock Performance

NASDAQ:OPCH traded down $0.07 during mid-day trading on Friday, hitting $28.68. 1,554,512 shares of the company's stock traded hands, compared to its average volume of 1,793,642. The firm has a 50 day moving average of $29.60 and a two-hundred day moving average of $31.65. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The firm has a market capitalization of $4.65 billion, a price-to-earnings ratio of 22.94, a price-to-earnings-growth ratio of 1.75 and a beta of 0.83.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The company had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.35 billion. During the same quarter last year, the company earned $0.30 EPS. The company's quarterly revenue was up 15.4% on a year-over-year basis. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, equities analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. Citigroup reaffirmed an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. JMP Securities upped their target price on Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research report on Thursday, July 31st. Finally, Barrington Research reiterated an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a research note on Thursday, July 10th. Eight research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $35.75.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.